Artiva Biotherapeutics, Inc. (ARTV) Operating margin 2023–2024
Artiva Biotherapeutics, Inc. (ARTV) operating margin by fiscal year — reported operating income divided by reported revenue.
-26805.6%FY2024 · since FY2023: -93.2% → -26805.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -26805.6% | -26712.4 pp |
| FY2023 | -93.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTV financial trends
ARTV RevenueARTV Net incomeARTV Net marginARTV Gross profitARTV Gross marginARTV Operating incomeARTV Operating cash flowARTV Free cash flowARTV Capital expendituresARTV Return on equityARTV Stock buybacksARTV Dividends paidARTV Total assetsARTV Total liabilitiesARTV Shareholders’ equityARTV overview →